These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6149938)

  • 1. Dose-response relationship of the beta-adrenoceptor antagonist bisoprolol in patients with coronary heart disease and chronic obstructive bronchitis.
    Dorow P; Tönnesmann U
    Eur J Clin Pharmacol; 1984; 27(2):135-9. PubMed ID: 6149938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta 1/beta 2-splitting of bisoprolol.
    Dorow P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S65-8. PubMed ID: 2439801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
    Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summary of short- and long-term studies with bisoprolol in coronary heart disease (CHD).
    Wagner G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S160-6. PubMed ID: 2439790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris.
    Dorow P; Bethge H; Tönnesmann U
    Eur J Clin Pharmacol; 1986; 31(2):143-7. PubMed ID: 2879733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bisoprolol on cardiac performance in coronary heart disease.
    Maisch B; Borst U; Gerhards W; Wagner G
    Eur J Clin Pharmacol; 1989; 36(3):217-22. PubMed ID: 2568261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of bisoprolol in patients with stable angina pectoris: a preliminary report.
    Kato K; Niitani H; Kanazawa T; Shimomura K; Toyama S
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S154-9. PubMed ID: 2439788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of bisoprolol in coronary heart disease. Effect on cardiovascular parameters and ischemic ST depression: studies on the duration of the effect].
    Prager G; Wagner G
    Dtsch Med Wochenschr; 1984 Dec; 109(50):1914-7. PubMed ID: 6150839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic effects of bisoprolol in patients with coronary heart disease: influence of various bisoprolol plasma concentrations.
    Bonelli J; Staribacher H
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S83-6. PubMed ID: 2439805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bisoprolol on exercise tolerance in patients with coronary heart disease: placebo-controlled double-blind crossover study.
    Schnellbacher K; Marsovszky E; Roskamm H
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S143-7. PubMed ID: 2439786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
    Tattersfield AE; Cragg DJ; Bacon RJ
    Br J Clin Pharmacol; 1984 Sep; 18(3):343-7. PubMed ID: 6148959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hemodynamic effects of bisoprolol, a new beta 1 selective adrenoreceptor blocking agent, in patients with coronary artery disease.
    Steinmann E; Pfisterer M; Burkart F
    J Cardiovasc Pharmacol; 1986; 8(5):1044-50. PubMed ID: 2429078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of different bisoprolol doses on hemodynamics, plasma catecholamines, platelet aggregation, and alpha 2- and beta-receptors in hypertensive patients.
    Kirsten R; Neff J; Heintz B; Nemeth N; Rahlfs VW; Nelson K
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S113-21. PubMed ID: 2439781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventilatory effects of beta 1-receptor-selective blockade with bisoprolol and metoprolol in asthmatic patients.
    Lammers JW; Folgering HT; van Herwaarden CL
    Eur J Clin Pharmacol; 1984; 27(2):141-5. PubMed ID: 6149939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol.
    Lipworth BJ; Irvine NA; McDevitt DG
    Eur J Clin Pharmacol; 1991; 40(2):135-9. PubMed ID: 1676675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
    Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
    Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bisoprolol in relation to metoprolol and bufuralol on left ventricular hemodynamics at rest and during exercise in chronic ischemic heart disease.
    Burkart F; Pfisterer M; Steinmann E
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S78-82. PubMed ID: 2439804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of bisoprolol and acebutolol in smokers with airway obstruction.
    Macquin-Mavier I; Roudot-Thoraval F; Clerici C; George C; Harf A
    Br J Clin Pharmacol; 1988 Sep; 26(3):279-84. PubMed ID: 2902873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
    Leopold G; Ungethüm W; Pabst J; Simane Z; Bühring KU; Wiemann H
    Br J Clin Pharmacol; 1986 Sep; 22(3):293-300. PubMed ID: 2876722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.